Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
62,326,221
-
Share change
-
+1,218,627
-
Total reported value
-
$9,805,597,971
-
Put/Call ratio
-
59%
-
Price per share
-
$157.33
-
Number of holders
-
282
-
Value change
-
+$244,032,456
-
Number of buys
-
161
-
Number of sells
-
104
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q1 2019
As of 31 Mar 2019,
BLUEBIRD BIO INC - COM (BLUE) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,326,221 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, Capital International Investors, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, Capital World Investors, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, and STATE STREET CORP.
This page lists
282
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.